Based in the United States, Arcus Bio is a startup.
Arcus Bio is a clinical-stage biopharmaceutical company developing small molecule and antibody therapies that target cancer through combination treatments focused on immuno-oncology pathways.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.